DARE: Daré Bioscience, Inc. Stock

by  •  • Comments Off on DARE: Daré Bioscience, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 25.75
Enterprise Value ($M) 14.55
Book Value ($M) -6.01
Book Value / Share -0.68
Price / Book -4.28
NCAV ($M) -9.67
NCAV / Share -1.09
Price / NCAV -2.66

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.31
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.85
Current Ratio 0.85

Balance Sheet (mrq) ($M)
Current Assets 18.45
Assets 22.10
Liabilities 28.11
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.01
Operating Income -23.45
Net Income -4.05
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 5.39
Cash from Investing -0.57
Cash from Financing 0.43

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 598 5,460 10.95
2025-04-16 92 1,881 4.89
2025-04-15 230 11,782 1.95
2025-04-14 467 8,393 5.56

(click for more detail)

Similar Companies
CYCC – Cyclacel Pharmaceuticals, Inc. CYCN – Cyclerion Therapeutics, Inc.
CYRX – Cryoport, Inc. DERM – Journey Medical Corporation
DMAC – DiaMedica Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io